Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
111M
-
Number of holders
-
28
-
Total 13F shares, excl. options
-
2.79M
-
Shares change
-
+418K
-
Total reported value, excl. options
-
$36.4M
-
Value change
-
+$4.81M
-
Put/Call ratio
-
0.43
-
Number of buys
-
17
-
Number of sells
-
-9
-
Price
-
$12.96
Significant Holders of Immunome Inc. - Common Stock, par value $0.0001 per share (IMNM) as of Q4 2021
40 filings reported holding IMNM - Immunome Inc. - Common Stock, par value $0.0001 per share as of Q4 2021.
Immunome Inc. - Common Stock, par value $0.0001 per share (IMNM) has 28 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.79M shares
of 111M outstanding shares and own 2.52% of the company stock.
Largest 10 shareholders include Alpine Global Management, LLC (862K shares), Prentice Capital Management, LP (807K shares), VANGUARD GROUP INC (376K shares), Cerity Partners LLC (94.7K shares), BANK OF MONTREAL /CAN/ (92.6K shares), GEODE CAPITAL MANAGEMENT, LLC (80K shares), MORGAN STANLEY (78.7K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (65.4K shares), Atom Investors LP (45.9K shares), and BlackRock Inc. (40.6K shares).
This table shows the top 28 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.